BioArctic Neuroscience (Sweden)

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

Chad J. Swanson, Yong Zhang, Shobha Dhadda et al. · Alzheimer s Research & Therapy · 2021 · 757 citations · Full text

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Maitrayee Sinha, Anna Ansell-Schultz, Livia Civitelli et al. · Acta Neuropathologica · 2018 · 491 citations · Full text

Justify your alpha

Daniël Lakens, Federico Adolfi, Casper J. Albers et al. · Nature Human Behaviour · 2018 · 467 citations · Full text

Philosophical Inquiry

Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease

Linda Söderberg, Malin Johannesson, Patrik Nygren et al. · Neurotherapeutics · 2022 · 387 citations · Full text

Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes

Jinar Rostami, Staffan Holmqvist, Veronica Lindström et al. · Journal of Neuroscience · 2017 · 324 citations · Full text